Why Regis Resources, Strike Energy, Telix, and Virgin Australia shares are falling today

These shares are starting the week in the red. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is out of form on Monday. In afternoon trade, the benchmark index is down 0.5% to 8,573.9 points.

Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:

a woman looks exhausted and overwhelmed as she slumps forward into her hand while looking at her laptop screen.

Image source: Getty Images

Regis Resources Ltd (ASX: RRL)

The Regis Resources share price is down 9% to $7.00. Investors have been selling this gold miner's shares following a pullback in the gold price. Traders have been selling gold amid concerns that sky-high oil prices could lead to higher inflation and force central banks to hike interest rates. It isn't just Regis Resources shares that are falling today. The S&P/ASX All Ordinaries Gold index is down 4.2% at the time of writing.

Strike Energy Ltd (ASX: STX)

The Strike Energy share price is down 3% to 10.7 cents. This morning, the energy company advised that the Western Australian Economic Regulation Authority (ERA) has finalised its Determination for the Benchmark Reserve Capacity Price (BRCP) for the 2028/29 Capacity Year at $488,500 per MW per annum. While this is a 35% increase on the 2027/28 benchmark of $360,700 per MW per year, it seems that some investors were expecting an even larger increase.

Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix Pharmaceuticals share price is down 3% to $10.96. This is despite the radiopharmaceuticals company revealing that it was optimistic that the resubmission of a new drug application (NDA) for its brain cancer imaging candidate TLX101-Px would be approved by the U.S. Food and Drug Administration (FDA). Telix's chief medical officer, Dr David N. Cade, said: "We appreciate the FDA's recognition of the critical unmet need to improve the diagnosis and management of glioma, particularly in the posttreatment setting. Our resubmission is supported by an extensive and compelling data set – particularly so for an orphan indication. We are grateful to our global clinical collaborators, who share our commitment to ensuring patients in the U.S. can benefit from this important patient management tool."

Virgin Australia Holdings Ltd (ASX: VGN)

The Virgin Australia share price is down 2.5% to $2.66. This may have been driven by concerns that rising oil prices could weigh on the profitability of the airline. Virgin Australia has also been struggling with its flights through to the Middle East with Qatar Airways experiencing consistent cancellations. The company's shares are now down almost 20% since this time last month.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Brainchip, Fortescue, IGO, and Life360 shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

a woman sits next to her computer screen with her head in her hands with the screens slowing graphs on downward trajectories.
52-Week Lows

Can the beaten-down CSL share price ever reach $300 again?

CSL is near decade lows. Can it ever climb back?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Bank of Queensland, Cochlear, Northern Star, and Paladin Energy shares are falling today

These shares are having a difficult time on hump day. But why?

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Share Fallers

Why ANZ, Challenger, Hub24, and Lynas shares are dropping today

These shares are under pressure on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Monash IVF, NAB, Viva Energy, and Worley shares are falling today

These shares are starting the week in the red. But why?

Read more »